Following customer reports of keyboard malfunctions on CareFusion's already-troubled Alaris infusion pump line, the FDA issues the highest level recall warning.


The FDA sent out the highest-risk recall notice for the an infusion pump made by CareFusion (NYSE:CFN), the most recent warning to customers involving the company's Alaris product line.

Following customer reports of an "error" message on the pump's PC computer system, the company issued a warning notice, which the FDA followed-up with a Class I recall, reserved for device malfunctions that have the potential cause serious harm or death.